Ann: Launch of Dapsone 5%, Gel in the United States, page-39

First 39 Last

Share
Profile

Follow
mamos

51 Posts.

20/04/24

19:36

Post #: 73440219
Share

Originally posted by Hadrian: ↑

To answer your questions, the reference to gAczone (Dapsone) is the generic version, both 5 and 7.5%, not the branded product that Mayne Pharma markets in the US and unless a manufacturer is able to circumvent the wholesalers and the PBMs their profits are non existent. Just 3 wholesalers in the US hold 95% of all generics distributed in the US and unless your product is the most competetive on price and gives them the best returns, it doesn't hit the shelves of pharmacies.

Mayne has a long and sad history of marketing generics in the US, having made over 1billion $ worth of losses over the last 8 years and although they are still a small part of their portfolio, they're now loss leaders in a wide range of branded and generic dermatologics to attract business from prescribers for the more profitable branded products in their portfolio. (ie they sell the generics at a loss to attract business for their other branded products)

Since the US government lifted the rules on number of generics and fast tracked approvals from the FDA, companies in this space have struggled , have a look at the share price of the biggest of them all TEVA $70 in 2015 down to $15 now.

Snapshot from Mayne Pharma's 2022 AGM

Expand

Hardrian send me a message [email protected] keen to chat on stocks.

ACR Price at posting: 6.0¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

FMG

Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI

NRX

Noronex joins forces with South32 to look for copper in Namibia

CC9

Wyoming could be America's next hard rock battery metal province – and Chariot Corporation can help

Talking Australia's very competitive property landscape: Realty Talks

AI stocks: What to expect in 2024-25

There are more pages in this discussion • 6 more messages in this thread...

First 39 Last

Add ACR (ASX) to my watchlist

(20min delay)
Last 6.3¢		Change -0.003(4.55%)		Mkt cap ! $18.31M

Open	High	Low	Value	Volume
6.7¢	6.7¢	6.3¢	$34.65K	539.8K

Buyers (Bids)

No.	Vol.	Price($)
1	123229	6.4¢

Sellers (Offers)

Price($)	Vol.	No.
7.0¢	235749	3

View Market Depth

No.	Vol.	Price($)
1	123229	0.064
1	4982	0.063
1	1700	0.062
2	76460	0.061
2	316666	0.060

Price($)	Vol.	No.
0.070	235749	3
0.072	47301	1
0.073	30000	3
0.075	149999	1
0.079	50000	1

Last trade - 14.04pm 18/07/2024 (20 minute delay)

ACR (ASX) Chart

Ann: Launch of Dapsone 5%, Gel in the United States, page-39

Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI

Noronex joins forces with South32 to look for copper in Namibia

Wyoming could be America's next hard rock battery metal province – and Chariot Corporation can help

Talking Australia's very competitive property landscape: Realty Talks

AI stocks: What to expect in 2024-25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Launch of Dapsone 5%, Gel in the United States, page-39

Top Stories

Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI

Noronex joins forces with South32 to look for copper in Namibia

Wyoming could be America's next hard rock battery metal province – and Chariot Corporation can help

Talking Australia's very competitive property landscape: Realty Talks

AI stocks: What to expect in 2024-25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News